Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells.

Moon JS, Lee MY, Park SW, Han WK, Hong SW, Ahn JH, Kim KS.

Prostate. 2008 Sep 15;68(13):1450-60. doi: 10.1002/pros.20817.

PMID:
18615458
2.

Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.

Huang H, Zegarra-Moro OL, Benson D, Tindall DJ.

Oncogene. 2004 Mar 18;23(12):2161-76.

PMID:
14676836
3.

Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells.

Yuan J, Liu X, Wu AW, McGonagill PW, Keller MJ, Galle CS, Meier JL.

J Virol. 2009 Jul;83(13):6391-403. doi: 10.1128/JVI.00061-09. Epub 2009 Apr 15.

4.

Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.

Gavrielides MV, Gonzalez-Guerrico AM, Riobo NA, Kazanietz MG.

Cancer Res. 2006 Dec 15;66(24):11792-801.

5.

Rap2 regulates androgen sensitivity in human prostate cancer cells.

Bigler D, Gioeli D, Conaway MR, Weber MJ, Theodorescu D.

Prostate. 2007 Oct 1;67(14):1590-9.

PMID:
17918750
6.

Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.

Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA.

Cell Signal. 2007 Feb;19(2):401-9. Epub 2006 Jul 25.

PMID:
16949795
7.

Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines.

Kline JN, Hunninghake GM, He B, Monick MM, Hunninghake GW.

Exp Lung Res. 1998 Jan-Feb;24(1):3-14.

PMID:
9457465
8.

Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.

Péant B, Diallo JS, Lessard L, Delvoye N, Le Page C, Saad F, Mes-Masson AM.

Mol Cancer Res. 2007 Jan;5(1):87-94.

9.

Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells.

Wang G, Jones SJ, Marra MA, Sadar MD.

Oncogene. 2006 Nov 23;25(55):7311-23. Epub 2006 Jun 5.

PMID:
16751804
10.

Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter.

Read JT, Rahmani M, Boroomand S, Allahverdian S, McManus BM, Rennie PS.

J Biol Chem. 2007 Nov 2;282(44):31954-63. Epub 2007 Aug 28.

11.

A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation.

Prösch S, Wendt CE, Reinke P, Priemer C, Oppert M, Krüger DH, Volk HD, Döcke WD.

Virology. 2000 Jul 5;272(2):357-65.

12.

The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.

Arnoldussen YJ, Lorenzo PI, Pretorius ME, Waehre H, Risberg B, Maelandsmo GM, Danielsen HE, Saatcioglu F.

Cancer Res. 2008 Nov 15;68(22):9255-64. doi: 10.1158/0008-5472.CAN-08-1224.

13.

JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.

Mehraein-Ghomi F, Lee E, Church DR, Thompson TA, Basu HS, Wilding G.

Prostate. 2008 Jun 15;68(9):924-34. doi: 10.1002/pros.20737.

PMID:
18386285
14.

Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.

Zhang HN, Yu CX, Zhang PJ, Chen WW, Jiang AL, Kong F, Deng JT, Zhang JY, Young CY.

Acta Pharmacol Sin. 2007 Mar;28(3):423-30.

15.

KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.

Lee MY, Moon JS, Park SW, Koh YK, Ahn YH, Kim KS.

Biochem J. 2009 Jan 1;417(1):313-22. doi: 10.1042/BJ20080762.

PMID:
18774944
16.

Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.

Butcher NJ, Tetlow NL, Cheung C, Broadhurst GM, Minchin RF.

Cancer Res. 2007 Jan 1;67(1):85-92.

17.

Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.

Moon JS, Jin WJ, Kwak JH, Kim HJ, Yun MJ, Kim JW, Park SW, Kim KS.

Biochem J. 2011 Jan 1;433(1):225-33. doi: 10.1042/BJ20101104.

PMID:
20958264
18.

Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.

McCarthy HO, Coulter JA, Worthington J, Robson T, Hirst DG.

J Gene Med. 2007 Jun;9(6):511-20.

PMID:
17471586
19.

A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.

Shankar E, Song K, Corum SL, Bane KL, Wang H, Kao HY, Danielpour D.

J Biol Chem. 2016 Mar 11;291(11):5512-26. doi: 10.1074/jbc.M115.694877. Epub 2016 Jan 19.

20.

Factors affecting human cytomegalovirus gene expression in human monocyte cell lines.

Lee CH, Lee GC, Chan YJ, Chiou CJ, Ahn JH, Hayward GS.

Mol Cells. 1999 Feb 28;9(1):37-44.

Supplemental Content

Support Center